JAMIE SZKODZINSKI: Open Payments
NPI 1396140166 · BRIGHTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 68 payments from 18 companies in 2025. Trend: 2023 $1,381 · 2024 $1,876 · 2025 $1,583
Food & beverage: $1,378Education: $205
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $314 |
| Janssen Biotech, Inc. | 11 | $207 |
| Regeneron Healthcare Solutions, Inc. | 5 | $151 |
| KYOWA KIRIN, INC. | 2 | $146 |
| Incyte Corporation | 5 | $123 |
| UCB, Inc. | 4 | $104 |
| LEO Pharma Inc. | 5 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| GENZYME CORPORATION | 3 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
Products named: TREMFYA, DUPIXENT, POTELIGEO, Winlevi, OPZELURA, Bimzelx, ILUMYA, ADBRY.
Industry payments across MI — which companies pay providers there.
